What obstacles stand in the way of faster development and launch of innovative new medicines and how can they be overcome?
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Presentation
- By: SCHULZE, Hermann (Mallinckrodt Pharmaceuticals Ltd, Switzerland)
Fast access of innovative medicines is not only of big interest of patients – it is also of big interest of the pharmaceutical industry. Drug development and obtaining marketing authorizations are the time-limiting hurdles to pass before medicines become available to patients. Drug development and drug approval can easily take 10 years. And the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.